DR. ANN BUTLER ZIMRIN, M.D.
Osteopathic Medicine at Greene St, Baltimore, MD

License number
Maryland D39639
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
22 S Greene St, Baltimore, MD 21201
Phone
(419) 328-2594
(410) 328-6896 (Fax)

Personal information

See more information about ANN BUTLER ZIMRIN at radaris.com
Name
Address
Phone
Ann Zimrin, age 68
115 Witherspoon Rd, Baltimore, MD 21212
(410) 433-3887
Ann B Zimrin, age 68
115 Witherspoon Rd, Baltimore, MD 21212
(410) 433-3887
Ann B Zimrin, age 68
1235 Crows Foot Rd, Marriottsville, MD 21104

Professional information

Ann Zimrin Photo 1

Ann Zimrin, Baltimore MD

Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology, Hematology
Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263
Education:
University of Chicago (1981), UCSF Medical Centers *Internal Medicine, Hospital of the University of PA *Medical Oncology


Ann B Zimrin Photo 2

Dr. Ann B Zimrin, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
(410) 328-7450 (Phone)
Languages:
English
Hospitals:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
Baltimore Washington Medical Center
301 Hospital Dr, Glen Burnie 21061
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1981
University Calif
Graduated: 1984
University Of Pennsylvania


Ann Zimrin Photo 3

Therapeutic And Diagnostic Methods And Compositions Based On Jagged/Notch Proteins And Nucleic Acids

US Patent:
6716974, Apr 6, 2004
Filed:
May 24, 2000
Appl. No.:
09/579536
Inventors:
Thomas Maciag - Freeport ME
Ann B. Zimrin - Baltimore MD
Deena J. Small - Scarborough ME
Igor A. Prudovsky - Old Orchard Beach ME
Assignee:
Maine Medical Center Research Institute - Scarborough ME
International Classification:
C07H 2104
US Classification:
536 235, 435 691, 435 991, 4352542, 4353201
Abstract:
This invention relates to therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids, and on their role in the signaling pathway relating to endothelial cell migration and/or differentiation. In addition, this invention provides a substantially purified Jagged protein, as well as a substantially purified nucleic acid or segment thereof encoding Jagged protein, or a functionally equivalent derivative, or allelic or species variant thereof. Further, this invention provides a substantially purified soluble Jagged protein and a substantially purified nucleic acid encoding same as well as a recombinant cell comprising a nucleic acid encoding a soluble Jagged protein. Soluble Jagged provides further therapeutic and diagnostic methods relating to diseases, disorders, and conditions involving Jagged/Notch signaling including, inter alia, angiogenesis, differentiation, and control of gene expression.


Ann Zimrin Photo 4

Therapeutic And Diagnostic Methods And Compositions Based On Jagged/Notch Proteins And Nucleic Acids

US Patent:
7304138, Dec 4, 2007
Filed:
Aug 28, 2003
Appl. No.:
10/650650
Inventors:
Thomas Maciag - Freeport ME, US
Ann B. Zimrin - Baltimore MD, US
Deena J. Small - Scarborough ME, US
Igor A. Prudovsky - Old Orchard Beach ME, US
Assignee:
Maine Medical Center Research Institute - Scarborough ME
International Classification:
C07K 14/435, C07K 14/515
US Classification:
530350, 530402, 536 235, 514 12
Abstract:
This invention relates to therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids, and on their role in the signaling pathway relating to endothelial cell migration and/or differentiation. In addition, this invention provides a substantially purified Jagged protein, as well as a substantially purified nucleic acid or segment thereof encoding Jagged protein, or a functionally equivalent derivative, or allelic or species variant thereof. Further, this invention provides a substantially purified soluble Jagged protein and a substantially purified nucleic acid encoding same as well as a recombinant cell comprising a nucleic acid encoding a soluble Jagged protein. Soluble Jagged provides further therapeutic and diagnostic methods relating to diseases, disorders, and conditions involving Jagged/Notch signaling including, inter alia, angiogenesis, differentiation, and control of gene expression.